Emerging Trends to Drive Cross-Species Organ Transplantation Market Growth at 8.3% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cross-Species Organ Transplantation Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been considerable growth in the size of the market for cross-species organ transplantation. It's projected that this market will expand from $13.98 billion in 2024 to reach $15.20 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.7%. Factors such as experimentation using animal models, emerging bioethics discussions, increasing chronic disease incidence, experimental pig-to-primate transplants, and high death rates due to end-stage organ failure have contributed to the historic period growth.

How Will the Cross-Species Organ Transplantation Market Size Evolve and Grow by 2029?
The market for cross-species organ transplantation is forecasted to experience robust growth in the coming years, increasing to $20.95 billion in 2029 with a compound annual growth rate (CAGR) of 8.3%. This projected surge can be linked to a rising requirement for organs that can be transplanted, proliferating investments in regenerative medicine, the worldwide prevalence of chronic kidney and liver diseases, the advocacy of patients for gaining access to transplants, and the dwindling supply of human providers. In terms of key trends over this period, the production of pig organs with edited genes, genome engineering compatible with humans, the deployment of artificial intelligence for organ matching, creation of vascular structures via 3D bioprinting, use of machine perfusion and preservation technology, and the application of nanoscale drug delivery for immunosuppression stand prevalent.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cross-species-organ-transplantation-global-market-report

What Drivers Are Propelling the Growth of Cross-Species Organ Transplantation Market Forward?
The accelerating trend towards genetic engineering is anticipated to boost the expansion of the cross-species organ transplantation market. Genetic engineering involves intentional alteration of an organism's DNA via biotechnology, either to introduce, eliminate, or change specific genes. This surge in genetic engineering intervention corresponds to the pressing need to resolve organ scarcity by producing animal organs more suitable for human transplantation. This, in turn, enhances the trajectory of the cross-species organ transplantation market as modified animal organs result in reduced immune rejection and increased compatibility for human transplants. For example, in July 2023, the American Society of Gene & Cell Therapy (ASGCT), a US non-profit medical and scientific body, reported that there were 247 gene therapies in Phase II at the close of the first quarter of 2023, escalating by 5% to 260 by the second quarter's conclusion. Therefore, the ongoing inclination towards genetic engineering is fueling the growth of the cross-species organ transplantation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp

What Are the Key Trends Driving Cross-Species Organ Transplantation Market Growth?
Principal businesses active in the cross-species organ transplantation market are concentrating on cementing strategic alliances to facilitate the authorization process for xenotransplantation solutions. A strategic collaboration is a cooperative agreement where firms leverage each other's strengths and resources to accomplish shared objectives, promoting growth, innovation, and competitiveness without consolidation. For example, in February 2025, United Therapeutics, a biotechnology firm based in the US, and eGenesis, a US-based pharmaceutical firm commenced clinical trials for pig kidney (xenotransplant) transplants in humans. Sanctioned by the U.S. Food and Drug Administration (FDA), this experiment anticipates transplanting genetically altered pig kidneys into patients struggling with kidney failure. The trials seek to counter the serious dearth of kidney donors, potentially introducing a fresh, sustainable organ supply for those in need.

What Are the Key Segments in the Cross-Species Organ Transplantation Market?
The cross-species organ transplantation market covered in this report is segmented

1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types
2) By Application: Kidney, Heart, Liver, Lung, Other Applications
3) By End-User: Transplant Centers, Hospitals, Other End-Users

Subsegments:
1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions
2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays
3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants
4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27267&type=smp

Who Are the Key Players Shaping the Cross-Species Organ Transplantation Market's Competitive Landscape?
Major companies operating in the cross-species organ transplantation market are Pfizer Inc, F. Hoffmann-la Roche Ltd, Sanofi SA, Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc.

What Geographic Markets Are Powering Growth in the Cross-Species Organ Transplantation Market?
North America was the largest region in the cross-species organ transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27267

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.